By: Jacqueline Carey, University of Illinois at Chicago From: medicalxpress.com A University of Illinois at Chicago-developed breast cancer drug that has the potential to help women whose cancer has stopped responding to hormone therapy recently entered its first human clinical trial. Breast cancer affects one in eight women in the United States, and while there are many types of breast …
Scientists develop system to rapidly and accurately detect tumor margins during breast cancer surgery
From: medicalxpress.com Scientists from the RIKEN Cluster for Pioneering Research (CPR), Osaka University, and collaborators have developed a new rapid and inexpensive way to accurately detect the margins between cancer and non-cancerous tissue during breast surgery. Their system is noteworthy in that it can detect the morphology of the cells, differentiating between cells that are more or less dangerous. Today, …
How prior authorization hobbles breast cancer care
Source: American Medical Association Staff Writer From: ama-assn.org A study examining the work required to meet prior-authorization (PA) requirements for breast cancer medications points to significant staff time lost securing permission for covered use. The drugs were nearly always approved as medically necessary. Researchers examined the processing steps and progress of prior-authorization requests covering 324 prescriptions for 279 breast cancer …
Breast Cancer and the Meaning of Today
When one receives a breast cancer diagnosis, your perspective is changed forever regardless of what you may believe. On an almost daily basis, I see and think about things in a whole new way, even years after I was diagnosed, treated and have been fortunate enough to have no evidence of disease. And I never realize this more than on …
Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
By: Christina Bennett, MS From: cancertherapyadvisor.com The addition of adjuvant capecitabine provided no survival benefit for patients with early triple-negative breast cancer who had undergone surgery and standard chemotherapy, according to a randomized, global, phase 3 GEICAM/CIBOMA clinical trial (ClinicalTrials.gov Identifier: NCT00130533). The exception to this, however, may be in patients with nonbasal-like disease. The trial results were presented at …
Multiple Oncotype DX Study Presentations at the 2018 San Antonio Breast Cancer Symposium Reinforce Real-world Value of the Oncotype DX Breast Recurrence Score® Test in Patients Regardless of Age or Race
News provided by: WCG/Genomic Health From: prnewswire.com Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple Oncotype DX Breast Recurrence Score® (RS) presentations at the 2018 San Antonio Breast Cancer Symposium® (SABCS), reinforcing the value of the Oncotype DX® test in optimizing treatment and outcomes in patients with both node-negative and node-positive early-stage breast cancer. Among the data presented …
Research From Scottsdale Radiation Oncologist, Dr. Robert Kuske, Presents Important Data in Stage 0,1, or 2 Breast Cancer
Source: Arizona Breast Cancer Specialists From: prnewswire.com Research from one of Scottsdale-based Arizona Breast Cancer Specialists‘ founders (a division of Arizona Center for Cancer Care), Robert Kuske, MD, was presented at the 2018 San Antonio Breast Cancer Symposium held December 4-8. The data suggests that a 5-day course of radiation treatment known as Partial Breast Irradiation (PBI) may be an …
Breast cancer vaccine that could save generations now in clinical trials at Mayo Clinic
By: Lena Harris From: kare11.com While the vaccine is still in clinical trials, doctors say they are very excited about it because it seems to be working with few negative side effects. The problem is, studies show less than 5 percent of adults with cancer enroll in trials. Tens of thousands of women die annually from breast cancer, but soon, …
Collaboration Promises Better, More Accurate Breast Cancer Diagnostics
From: PR Newswire Data-sharing result s in an improved method of HER2 protein analysis which promises more accurate breast cancer diagnosis results. The Health Exchange Market, or T.H.E.M.™, together with LabCorp, Konica Minolta, Inc. University of Rochester, Penn State Hershey Medical Center and Lebanon VA Medical Center, has presented significant findings in breast cancer research at the 2018 San Antonio …
12 myths about cancer, debunked
Presented by Cancer Treatment Centers of America From: tulsaworld.com When it comes to cancer, there are many myths that get passed around by well-meaning friends and family members. Those myths can end up causing more stress for patients than they were already experiencing. Because understanding your diagnosis is an essential part of moving forward with your treatment plan, here are …